Bio Association Genome Enterprise Council Elects Choi Dae-chul as New Chairman

The Genome Companies Council under the Korea Bio Association announced on the 24th that Choi Dae-chul, CEO of NGeneBio, has been appointed as the next chairman.

At the Genome Enterprise Council general meeting held on the 22nd, former chairman Hwang Tae-soon, CEO of Theragen Bio, and new chairman Choi Dae-chul, CEO of Ngen Bio, are taking a commemorative photo. (From left) [Photo by Korea Bio Association]

The Genome Companies Council held a general meeting on the 22nd and elected Chairman Choi and new executives.

The term of the newly elected chairman and executives will be two years, from the 1st of next month until August 30, 2025. Shin Dong-jik, CEO of Medizen Human Care, was appointed as vice chairman, and Teragen Bio, Macrogen, DNA Link, LabGenomics, and AccuGene were elected as operating committee members.

The Genome Companies Council, established in 2015 as an official consultative body of domestic genome-related companies, aims to conduct research and respond to regulations related to genome analysis service licensing and to improve policies. Currently, 28 companies are members. The council has promoted government-related activities and cooperation among companies for the development of the domestic genome industry, including revising the Bioethics Act and introducing formal certification regulations for Direct-to-Consumer (DTC) testing.

In April and June, the council held consecutive meetings attended by health authorities to gather opinions from the industry. Through this, the council explained that it is striving to activate bio-genome research and industry and to create an organic cooperative environment within the domestic bio-ecosystem.

In his inaugural speech, newly appointed Chairman Choi Dae-chul said, "Internally, we will expand membership and strengthen unity among companies, and externally, we will actively promote government-related activities to ensure the proper use of genome products and services and the development of related industries." He added, "We will lead the activation of the domestic genome industry by expanding beyond the DTC field, enhancing mutual exchange among members, and fostering close cooperation with other industries."

Meanwhile, at the general meeting, a plaque of appreciation was awarded to former chairman Hwang Tae-soon for his contributions to the development of the council.

This content was produced with the assistance of AI translation services.